-
Organigram Invests Additional $2.5M In CBD Biotech Co Hyasynth, Wraps Up $10M Debenture Purchase Deal
Wednesday, December 22, 2021 - 1:37pm | 527Read More...Organigram Holdings Inc. (NASDAQ: OGI) (TSX:OGI) has acquired an additional $2.5 million of secured convertible debentures in Hyasynth Biologicals Inc. The move follows the second $2.5 million tranches of financing under the $10 million debenture purchase deal between Organigram Inc. – a...
-
Sterne Agee CRT Still Buying Micron After Meeting With Management
Friday, June 10, 2016 - 3:58pm | 320Read More...After a two-day investor meet, Sterne Agee CRT analysts Douglas Freedman and Kevin Chen remain buyers of Micron Technology, Inc. (NASDAQ: MU) shares. The brokerage also kept a price target of $18.00 on the stock. The brokerage believes the continued bit production ramp of 20nm DRAM and 3D NAND in...
-
Pacific Crest Raises NXP Semiconductors Price Target As FSL Acquisition Provides 'Synergies and Long-Term Sustainability'
Tuesday, March 3, 2015 - 4:21pm | 270Read More...In a report published Monday, analysts John Vinh and Kevin Chen at Pacific Crest raised their price target on NXP Semiconductors NV's (NASDAQ: NXPI) from $95 to $135 and maintained an Outperform rating. On Monday, news came out about NXP planning to buy smaller peer Freescale Semiconductor...
